FTI Consulting Adds John Siedlecki to Health Solutions Practice
Mar 29, 2017 11:31 am UTC| Business
WASHINGTON, March 29, 2017 -- FTI Consulting, Inc. (NYSE:FCN) today announced that the firm’s Health Solutions practice within the Forensic Litigation Consulting segment has added John Siedlecki as a Senior Managing...
CBI Telecommunication Consultants Kicks Off AOTMP Efficiency First® Solution Re-Certification
Mar 29, 2017 11:30 am UTC| Business
INDIANAPOLIS, March 29, 2017 -- AOTMP is pleased to announce that CBI Telecommunications Consultants is recertifying its Global Technology Expense Management GTEM Solutions™ in AOTMP’s Efficiency First® Vendor Solution...
Matinas BioPharma to Host Fiscal Year 2016 Update Conference Call
Mar 29, 2017 11:05 am UTC| Business
BEDMINSTER, N.J., March 29, 2017 -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, today announced...
Hunt Mining Announces Second Delivery of Concentrate from Martha Mine
Mar 29, 2017 11:03 am UTC| Business
LIBERTY LAKE, Wash., March 29, 2017 -- Hunt Mining Corp. ("Hunt" or the "Corporation") (TSXV:HMX) is pleased to announce the second delivery of concentrate from production activities at the Martha Mine Project (“Martha...
Mar 29, 2017 11:02 am UTC| Business
OXFORD, United Kingdom, March 29, 2017 -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy (‘DMD’) and C. difficile...
Mar 29, 2017 11:02 am UTC| Business
OXFORD, United Kingdom, March 29, 2017 -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy (‘DMD’) and C. difficile...
Axsome Therapeutics Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares
Mar 29, 2017 11:01 am UTC| Business
NEW YORK, March 29, 2017 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced...